CMR reveals myocardial damage from cardiotoxic oncologic therapies in breast cancer patients.

Publication

CMR reveals myocardial damage from cardiotoxic oncologic therapies in breast cancer patients.

Journal Paper/Review - Nov 25, 2023

Kersten Johannes, Fink Visnja, Kersten Maria, May Lisa, Nunn Samuel, Tadic Marijana, Huober Jens, Bekes Inga, Radermacher Michael, Hombach Vinzenz, Rottbauer Wolfgang, Buckert Dominik

Citation

Kersten J, Fink V, Kersten M, May L, Nunn S, Tadic M, Huober J, Bekes I, Radermacher M, Hombach V, Rottbauer W, Buckert D. CMR reveals myocardial damage from cardiotoxic oncologic therapies in breast cancer patients. Int J Cardiovasc Imaging 2023

Type

Journal Paper/Review (English)

Journal

Int J Cardiovasc Imaging 2023

Publication Date

Nov 25, 2023

Issn Electronic

1875-8312

Brief description/objective

Breast cancer is a common and increasingly treatable disease. However, survivors have a significantly elevated risk of cardiac events afterwards. This study aimed to characterise cardiac changes during cardiotoxic cancer therapy using cardiovascular magnetic resonance (CMR) imaging.